Factor | ||
---|---|---|
Patients | 22 | |
Cases | 23 | |
Age (years, mean ± SD) | 72.0 ± 13.0 (range, 36–90) | |
Sex (male/female) | 11/11 | |
Indication (pseudoaneurysm/extravasation/inadvertent arterial cannulation) | 13/9/1 | |
Location of the artery (BCA/SCA/AXA/BA/CIA/EIA/CFA/SFA/POP) | 1/3/1/1/4/8/2/2/1 | |
Approach site (femoral/axillary/brachial/radial) | 20/1/1/1 | |
Artery diameter (mm, mean ± SD) | 7.7 ± 2.2 (range, 5–12) | |
Stent graft diameter (mm, mean ± SD) | 8.9 ± 2.3 (range, 6–13) | |
Stent graft oversizing (%, mean ± SD) | 16.1 ± 7.8 (range, 0–33) | |
Stent graft length (5/10 cm) | 20/8 | |
Neck length (mm, mean ± SD) | 20.4 ± 11.3 (range, 3–50) | |
Branch artery embolization | 3 | |
Procedure time (min, mean ± SD) | 35.5 ± 21.2 (range, 8–86) | |
Technical success (%) | 100 | |
Clinical success (%) | 100 | |
Limb ischemia (%) | 0 | |
Periprocedural complications (%) | 0 | |
Bleeding-related mortality (%) | 0 | |
30-day mortality (%) | 22.7 | |
Anticoagulation therapy (%) | 77.3 | |
CTA follow-up duration (days, mean ± SD) | 168.8 ± 176.5 (range, 3–655) | |
Rebleeding (%) | 0 | |
Endoleaks (%) | 0 | |
Stent graft patency (%) | 1 month | 91.7 |
3 months | 91.7 | |
6 months | 81.5 | |
12 months | 81.5 |